Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · August 10, 2020

Safety and Immunogenicity of the ChAdOx1 nCoV-19 Vaccine Against SARS-CoV-2

The Lancet

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet
Safety and Immunogenicity of the ChAdOx1 nCoV-19 Vaccine Against SARS-CoV-2: A Preliminary Report of a Phase 1/2, Single-Blind, Randomised Controlled Trial
Lancet 2020 Jul 20;[EPub Ahead of Print], PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, S Belij-Rammerstorfer, D Bellamy, S Bibi, M Bittaye, EA Clutterbuck, C Dold, SN Faust, A Finn, AL Flaxman, B Hallis, P Heath, D Jenkin, R Lazarus, R Makinson, AM Minassian, KM Pollock, M Ramasamy, H Robinson, M Snape, R Tarrant, M Voysey, C Green, AD Douglas, AVS Hill, T Lambe, SC Gilbert, AJ Pollard

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading